Alentis Therapeutics is a clinical-stage biopharmaceutical company based in Basel, Switzerland. Founded in 2019, it focuses on developing a wide range of targeted therapies for cancer, tumors, and organ fibrosis. It helps researchers treat liver cirrhosis, liver cancer, and liver fibrosis in patients.